SynCore Biotechnology Co.,Ltd (4192.TWO)
TWD 30.0
(0.0%)
TWD 30.0
(0.0%)
| Breakdown | 2023 | 2022 | 2021 | 2020 | 2019 |
|---|---|---|---|---|---|
| Operating Cash Flow | -82.37 Million | -209.61 Million | -229.86 Million | -316.63 Million | - |
| Net Income | -38.17 Million | -188.66 Million | -458.59 Million | -398.91 Million | - |
| Depreciation & Amortization | 19.66 Million | 40.07 Million | 52.43 Million | 56.46 Million | - |
| Deferred income taxes | - | - | - | - | - |
| Stock-based compensation | - | - | - | - | - |
| Change in working capital | -3.45 Million | -61.08 Million | 176.36 Million | 27.73 Million | - |
| Other non-cash items | -61.96 Million | 847 Thousand | 1.01 Million | 2.15 Million | - |
| Investing Cash Flow | -778 Thousand | -1.03 Million | -1.63 Million | -5.64 Million | - |
| Investments in PPE | -761 Thousand | -1.03 Million | -1.63 Million | -6.02 Million | - |
| Acquisitions | - | - | - | - | - |
| Investment purchases | - | - | - | - | - |
| Sales/Maturities of investments | - | - | - | - | - |
| Other Investing Activities | -17 Thousand | - | - | -13 Thousand | 1.45 Million |
| Financing Cash Flow | 78.67 Million | -73.21 Million | 245.31 Million | 475.13 Million | - |
| Debt repayment | -60 Million | -60 Million | -90 Million | -170 Million | - |
| Dividends payments | - | - | - | - | - |
| Common Stock Repurchased | - | - | - | - | - |
| Common Stock Issuance | 149.28 Million | - | 348.5 Million | 349.98 Million | - |
| Other Financing Activities | -10.6 Million | - | - | -31.85 Million | -33.88 Million |
| Accounts receivables | -788 Thousand | - | - | - | - |
| Accounts payables | -315 Thousand | - | - | - | - |
| Inventory | 14.35 Million | -298 Thousand | 669 Thousand | -14.98 Million | - |
| Other working capital | -17.02 Million | - | - | - | - |
| Cash at beginning of period | 269.14 Million | 552.97 Million | 539.23 Million | 386.35 Million | - |
| Cash at end of period | 264.69 Million | 269.14 Million | 552.97 Million | 539.23 Million | - |
| Capital Expenditure | -761 Thousand | -1.03 Million | -1.63 Million | -6.02 Million | - |
| Effect of forex changes on cash | 27 Thousand | 30 Thousand | -76 Thousand | 29 Thousand | - |
| Net cash flow / Change in cash | -4.44 Million | -283.82 Million | 13.73 Million | 152.88 Million | - |
| Free Cash Flow | -83.13 Million | -210.64 Million | -231.49 Million | -322.65 Million | - |
| Breakdown | 2024 Q2 | 2024 Q1 | 2023 FY | 2023 Q4 | 2023 Q3 | 2023 Q2 |
|---|---|---|---|---|---|---|
| Operating Cash Flow | - | - | - | - | - | - |
| Net Income | -13.49 Million | -13.37 Million | -38.17 Million | 41.61 Million | -29.46 Million | -26.39 Million |
| Depreciation & Amortization | 4.54 Million | 4.57 Million | 19.66 Million | 4.57 Million | 4.62 Million | 4.68 Million |
| Deferred income taxes | - | - | - | - | - | - |
| Stock-based compensation | - | - | - | - | - | - |
| Change in working capital | -4.52 Million | -11.5 Million | -3.45 Million | -15.98 Million | 11.13 Million | 11.29 Million |
| Other non-cash items | -710 Thousand | -322 Thousand | -61.96 Million | -60.98 Million | -423 Thousand | -381 Thousand |
| Investing Cash Flow | - | -244 Thousand | -778 Thousand | -184 Thousand | -102 Thousand | -186 Thousand |
| Investments in PPE | - | -244 Thousand | -761 Thousand | -154 Thousand | -115 Thousand | -186 Thousand |
| Acquisitions | - | - | - | - | - | - |
| Investment purchases | - | - | - | - | - | - |
| Sales/Maturities of investments | - | - | - | - | - | - |
| Other Investing Activities | - | - | -17 Thousand | -30 Thousand | - | - |
| Financing Cash Flow | -2.34 Million | -2.41 Million | 78.67 Million | 146.83 Million | -62.43 Million | -2.42 Million |
| Debt repayment | -2.34 Million | - | -60 Million | - | -60 Million | - |
| Dividends payments | - | - | - | - | - | - |
| Common Stock Repurchased | - | - | - | - | - | - |
| Common Stock Issuance | - | - | 149.28 Million | - | - | - |
| Other Financing Activities | -2.34 Million | - | - | - | - | - |
| Accounts receivables | -1.12 Million | - | - | - | - | - |
| Accounts payables | 366 Thousand | - | - | - | - | - |
| Inventory | 1.2 Million | -4.92 Million | 14.35 Million | 12.08 Million | 1.64 Million | 1.96 Million |
| Other working capital | -5.02 Million | - | - | - | - | - |
| Cash at beginning of period | 241.75 Million | 264.69 Million | 269.14 Million | 148.17 Million | 224.43 Million | 237.45 Million |
| Cash at end of period | 225.93 Million | 241.75 Million | 264.69 Million | 264.69 Million | 148.17 Million | 224.43 Million |
| Capital Expenditure | - | -244 Thousand | -761 Thousand | -154 Thousand | -115 Thousand | -186 Thousand |
| Effect of forex changes on cash | 6000.00 | 10 Thousand | 27 Thousand | 2000.00 | 2000.00 | 14 Thousand |
| Net cash flow / Change in cash | -15.82 Million | -22.94 Million | -4.44 Million | 116.52 Million | -76.25 Million | -13.02 Million |
| Free Cash Flow | -13.48 Million | -20.53 Million | -83.13 Million | -30.29 Million | -13.83 Million | -10.61 Million |
8930
3184
3DP
BYCBF
CORG
DRE